title: What the public knows and wants to know about medicines research and development: a survey of the general public in six European countries.
abstract: OBJECTIVE
  To explore public knowledge of, and interest in, learning more about medicines R&D in six European countries.
  
  
  METHODS
  Online survey of 6931 members of the public across Europe.
  
  
  METHODS
  The survey formed part of a public omnibus survey. A quota sampling approach was used with quotas set according to national census data on age, gender and government region. The survey explored the public's knowledge and awareness of medicines R&D, their interest in learning more and the perceived influences on this.
  
  
  RESULTS
  The survey was completed by 6931 members of the public, over 75% of whom reported having no or less than good knowledge of medicines R&D. Males were more likely than females to report good knowledge (17% vs 15%), and knowledge appeared to decrease with age. Those who were currently or had previously been involved in medical research were almost five times more likely to report good knowledge of medicines R&D overall (43% vs 13%). Participants reported good knowledge of medicines safety and clinical trials but little knowledge of pharmacoeconomics. They were most interested in learning more about medicines safety and personalised and predictive medicine and least interested in pharmacoeconomics. Older people, women and respondents with current good knowledge of medicines R&D were most interested in learning more about medicines R&D.
  
  
  CONCLUSIONS
  Experience of medical research appears to play a key role in increasing public awareness of and future interest in medicines R&D. Some groups may need to be specifically targeted to increase their awareness of medicines R&D, for example, women expressed great interest in learning more but reported less knowledge than men. It may be useful to explore further the views of those who are currently uninterested in learning more.
authors: Public Programmes Team, Central Manchester University Hospitals NHS Foundation Trust & University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
authors: Suzanne
authors: S
authors: Parsons
authors: Public Programmes Team, Central Manchester University Hospitals NHS Foundation Trust & University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
authors: Bella
authors: B
authors: Starling
authors: Public Health Evidence and Insights, Global Public Affairs, Novo Nordisk, A/S, Copenhagen, Denmark.
authors: Christine
authors: C
authors: Mullan-Jensen
authors: Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK.
authors: Su-Gwan
authors: http://orcid.org/0000-0003-2526-817X
authors: SG
authors: Tham
authors: Focus on the Patient, Medical Platforms UK, GlaxoSmithKline, London, UK.
authors: Kay
authors: K
authors: Warner
authors: Department of Research and International Affairs, Dutch Genetic Alliance (VSOP), Soest, The Netherlands.
authors: Kim
authors: K
authors: Wever
mesh_terms: D000328:Adult; D000367:Age Factors; D001364:Awareness; D035843:Biomedical Research; D055808:Drug Discovery; D005060:Europe; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D008875:Middle Aged; D011639:Public Opinion; D012737:Sex Factors; D011795:Surveys and Questionnaires; D055815:Young Adult
keywords: PUBLIC HEALTH; Research methods; SOCIAL MEDICINE